Table 1.
Clinical Characteristic of the Patients.a
| Characteristics | Values |
|---|---|
| Age (years) | 57.73 (10.98) |
| Sex | |
| Male | 20 |
| Female | 6 |
| Tumor location | |
| Perivascular | 10 |
| Subdiaphragmatic | 6 |
| Subcapsular | 5 |
| Perivascular and subdiaphragmatic | 5 |
| Maximum tumor diameter (cm) | 2.12 (0.62) |
| AFP | |
| >400 ng/mL | 3 |
| ≤400 ng/mL | 23 |
| ECOG (0/1) | 23/3 |
| Previous treatment history | 12 |
| Surgery | 3 |
| Ablation (RFA or MWA) | 1 |
| TACE | 2 |
| Surgery and TACE | 4 |
| Ablation and TACE | 1 |
| Transplantation, ablation, and TACE | 1 |
Abbreviations: AFP, α-fetoprotein; ECOG, eastern cooperative oncology group; MWA, microwave ablation; RFA, radiofrequency ablation; TACE, transarterial chemoembolization.
a N = 26.